Time course and pattern of COPD exacerbation onset

BackgroundThe natural history and time course of the onset of exacerbation events of chronic obstructive pulmonary disease (COPD) is incompletely understood.MethodsA prospective cohort of 212 patients with COPD was monitored using daily symptom diaries for a median of 2.8 years to characterise the t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thorax 2012-03, Vol.67 (3), p.238-243
Hauptverfasser: Aaron, Shawn D, Donaldson, Gavin C, Whitmore, George A, Hurst, John R, Ramsay, Tim, Wedzicha, Jadwiga A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 243
container_issue 3
container_start_page 238
container_title Thorax
container_volume 67
creator Aaron, Shawn D
Donaldson, Gavin C
Whitmore, George A
Hurst, John R
Ramsay, Tim
Wedzicha, Jadwiga A
description BackgroundThe natural history and time course of the onset of exacerbation events of chronic obstructive pulmonary disease (COPD) is incompletely understood.MethodsA prospective cohort of 212 patients with COPD was monitored using daily symptom diaries for a median of 2.8 years to characterise the time course of COPD exacerbation onset. Decision rules based on weighted self-reported symptoms were used to define opening and closing of exacerbation events. Event time intervals were analysed and logistic regression was used to determine the effects of patient covariates on exacerbation events.ResultsPatients recorded 4439 episodes of worsening respiratory symptoms from baseline; 2444 (55%) events resolved spontaneously and 1995 (45%) resulted in a COPD exacerbation. In 1115 of the 1995 COPD exacerbations (56%) the onset was sudden and the exacerbation threshold was crossed on the same day symptoms began. In contrast, 44% of exacerbations were characterised by gradual onset of symptoms (median duration from symptom onset to exacerbation 4 days). Patients who experienced sudden onset exacerbations had greater mean daily symptom scores (7.86 vs 6.55 points, p
doi_str_mv 10.1136/thoraxjnl-2011-200768
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_922501692</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4027103741</sourcerecordid><originalsourceid>FETCH-LOGICAL-b558t-cbe6ed64e040d6680a63b8a5a55cc07ae6c48906d03863badb4f97af2a80e4a13</originalsourceid><addsrcrecordid>eNqNkVtP3DAQha0KVJbLT2gVCVU8BcZOfMkj3V4AIeABeLUmzkTNNpfFzkrLv8erbLcST7zY1pxvRmeOGfvC4ZzzTF2MfwaP60XfpgI4jwdoZT6xGc-VSTNRqD02A8ghVZlWB-wwhAUAGM71Z3YgxOZpihkTj01HiRtWPlCCfZUscRzJ98lQJ_P7hx8JrdGRL3FshljsA43HbL_GNtDJ9j5iT79-Ps6v0tv739fzy9u0lNKMqStJUaVyiiYqpQygykqDEqV0DjSScrkpQFWQmahgVeZ1obEWaIBy5NkRO5vmLv3wsqIw2q4JjtoWexpWwRZCSOCqEJE8fUcu4kJ9NGe5jntyoQuIlJwo54cQPNV26ZsO_avlYDeZ2l2mdpOpnTKNfV-301dlR9Wu61-IEfi2BTA4bGuPvWvCf04aHX9FRy6duCaMtN7p6P_aqGpp757nlht4zoobbb9HHia-7BYf9PoGQD-eZQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781812790</pqid></control><display><type>article</type><title>Time course and pattern of COPD exacerbation onset</title><source>MEDLINE</source><source>BMJ Journals - NESLi2</source><source>Alma/SFX Local Collection</source><creator>Aaron, Shawn D ; Donaldson, Gavin C ; Whitmore, George A ; Hurst, John R ; Ramsay, Tim ; Wedzicha, Jadwiga A</creator><creatorcontrib>Aaron, Shawn D ; Donaldson, Gavin C ; Whitmore, George A ; Hurst, John R ; Ramsay, Tim ; Wedzicha, Jadwiga A</creatorcontrib><description>BackgroundThe natural history and time course of the onset of exacerbation events of chronic obstructive pulmonary disease (COPD) is incompletely understood.MethodsA prospective cohort of 212 patients with COPD was monitored using daily symptom diaries for a median of 2.8 years to characterise the time course of COPD exacerbation onset. Decision rules based on weighted self-reported symptoms were used to define opening and closing of exacerbation events. Event time intervals were analysed and logistic regression was used to determine the effects of patient covariates on exacerbation events.ResultsPatients recorded 4439 episodes of worsening respiratory symptoms from baseline; 2444 (55%) events resolved spontaneously and 1995 (45%) resulted in a COPD exacerbation. In 1115 of the 1995 COPD exacerbations (56%) the onset was sudden and the exacerbation threshold was crossed on the same day symptoms began. In contrast, 44% of exacerbations were characterised by gradual onset of symptoms (median duration from symptom onset to exacerbation 4 days). Patients who experienced sudden onset exacerbations had greater mean daily symptom scores (7.86 vs 6.55 points, p&lt;0.001), greater peak symptom scores (10.7 vs 10.2 points, p=0.003), earlier peak symptoms (4.5 vs 8.0 days, p&lt;0.001) and shorter median recovery times back to baseline health status (11 vs 13 days, p&lt;0.001). Multivariable analysis showed that gradual onset exacerbations were statistically associated with a longer duration of exacerbation recovery (OR 1.28, 95% CI 1.06 to 1.54, p=0.010).ConclusionsCOPD exacerbations exhibit two distinct patterns—sudden and gradual onset. Sudden onset exacerbations are associated with increased respiratory symptoms but shorter exacerbation recovery times.</description><identifier>ISSN: 0040-6376</identifier><identifier>EISSN: 1468-3296</identifier><identifier>DOI: 10.1136/thoraxjnl-2011-200768</identifier><identifier>PMID: 22008189</identifier><identifier>CODEN: THORA7</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Thoracic Society</publisher><subject>Acute Disease ; Aged ; Anti-Bacterial Agents - therapeutic use ; Biological and medical sciences ; bronchiectasis ; Cardiology. Vascular system ; Chronic obstructive pulmonary disease ; Chronic obstructive pulmonary disease, asthma ; COPD epidemiology ; COPD exacerbations ; COPD mechanisms ; COPD pathology ; COPD pharmacology ; cystic fibrosis ; Diaries ; diary data ; Disease Progression ; event history analysis ; exacerbation ; Female ; Forced Expiratory Volume - physiology ; Glucocorticoids - therapeutic use ; health process ; Humans ; Infections ; logistic regression ; lung physiology ; Male ; Medical sciences ; medication ; Middle Aged ; Patients ; Pneumology ; Prognosis ; Prospective Studies ; Pulmonary Disease, Chronic Obstructive - complications ; Pulmonary Disease, Chronic Obstructive - drug therapy ; Pulmonary Disease, Chronic Obstructive - physiopathology ; Respiration Disorders - etiology ; Respiration Disorders - physiopathology ; Respiratory Tract Infections - complications ; Respiratory Tract Infections - drug therapy ; Risk Factors ; score function ; symptoms ; Time Factors ; Viral infections ; Vital Capacity - physiology</subject><ispartof>Thorax, 2012-03, Vol.67 (3), p.238-243</ispartof><rights>2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright: 2012 (c) 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b558t-cbe6ed64e040d6680a63b8a5a55cc07ae6c48906d03863badb4f97af2a80e4a13</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://thorax.bmj.com/content/67/3/238.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttps://thorax.bmj.com/content/67/3/238.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,780,784,3194,23570,27923,27924,77371,77402</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25871467$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22008189$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aaron, Shawn D</creatorcontrib><creatorcontrib>Donaldson, Gavin C</creatorcontrib><creatorcontrib>Whitmore, George A</creatorcontrib><creatorcontrib>Hurst, John R</creatorcontrib><creatorcontrib>Ramsay, Tim</creatorcontrib><creatorcontrib>Wedzicha, Jadwiga A</creatorcontrib><title>Time course and pattern of COPD exacerbation onset</title><title>Thorax</title><addtitle>Thorax</addtitle><description>BackgroundThe natural history and time course of the onset of exacerbation events of chronic obstructive pulmonary disease (COPD) is incompletely understood.MethodsA prospective cohort of 212 patients with COPD was monitored using daily symptom diaries for a median of 2.8 years to characterise the time course of COPD exacerbation onset. Decision rules based on weighted self-reported symptoms were used to define opening and closing of exacerbation events. Event time intervals were analysed and logistic regression was used to determine the effects of patient covariates on exacerbation events.ResultsPatients recorded 4439 episodes of worsening respiratory symptoms from baseline; 2444 (55%) events resolved spontaneously and 1995 (45%) resulted in a COPD exacerbation. In 1115 of the 1995 COPD exacerbations (56%) the onset was sudden and the exacerbation threshold was crossed on the same day symptoms began. In contrast, 44% of exacerbations were characterised by gradual onset of symptoms (median duration from symptom onset to exacerbation 4 days). Patients who experienced sudden onset exacerbations had greater mean daily symptom scores (7.86 vs 6.55 points, p&lt;0.001), greater peak symptom scores (10.7 vs 10.2 points, p=0.003), earlier peak symptoms (4.5 vs 8.0 days, p&lt;0.001) and shorter median recovery times back to baseline health status (11 vs 13 days, p&lt;0.001). Multivariable analysis showed that gradual onset exacerbations were statistically associated with a longer duration of exacerbation recovery (OR 1.28, 95% CI 1.06 to 1.54, p=0.010).ConclusionsCOPD exacerbations exhibit two distinct patterns—sudden and gradual onset. Sudden onset exacerbations are associated with increased respiratory symptoms but shorter exacerbation recovery times.</description><subject>Acute Disease</subject><subject>Aged</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>bronchiectasis</subject><subject>Cardiology. Vascular system</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Chronic obstructive pulmonary disease, asthma</subject><subject>COPD epidemiology</subject><subject>COPD exacerbations</subject><subject>COPD mechanisms</subject><subject>COPD pathology</subject><subject>COPD pharmacology</subject><subject>cystic fibrosis</subject><subject>Diaries</subject><subject>diary data</subject><subject>Disease Progression</subject><subject>event history analysis</subject><subject>exacerbation</subject><subject>Female</subject><subject>Forced Expiratory Volume - physiology</subject><subject>Glucocorticoids - therapeutic use</subject><subject>health process</subject><subject>Humans</subject><subject>Infections</subject><subject>logistic regression</subject><subject>lung physiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>medication</subject><subject>Middle Aged</subject><subject>Patients</subject><subject>Pneumology</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Pulmonary Disease, Chronic Obstructive - complications</subject><subject>Pulmonary Disease, Chronic Obstructive - drug therapy</subject><subject>Pulmonary Disease, Chronic Obstructive - physiopathology</subject><subject>Respiration Disorders - etiology</subject><subject>Respiration Disorders - physiopathology</subject><subject>Respiratory Tract Infections - complications</subject><subject>Respiratory Tract Infections - drug therapy</subject><subject>Risk Factors</subject><subject>score function</subject><subject>symptoms</subject><subject>Time Factors</subject><subject>Viral infections</subject><subject>Vital Capacity - physiology</subject><issn>0040-6376</issn><issn>1468-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNkVtP3DAQha0KVJbLT2gVCVU8BcZOfMkj3V4AIeABeLUmzkTNNpfFzkrLv8erbLcST7zY1pxvRmeOGfvC4ZzzTF2MfwaP60XfpgI4jwdoZT6xGc-VSTNRqD02A8ghVZlWB-wwhAUAGM71Z3YgxOZpihkTj01HiRtWPlCCfZUscRzJ98lQJ_P7hx8JrdGRL3FshljsA43HbL_GNtDJ9j5iT79-Ps6v0tv739fzy9u0lNKMqStJUaVyiiYqpQygykqDEqV0DjSScrkpQFWQmahgVeZ1obEWaIBy5NkRO5vmLv3wsqIw2q4JjtoWexpWwRZCSOCqEJE8fUcu4kJ9NGe5jntyoQuIlJwo54cQPNV26ZsO_avlYDeZ2l2mdpOpnTKNfV-301dlR9Wu61-IEfi2BTA4bGuPvWvCf04aHX9FRy6duCaMtN7p6P_aqGpp757nlht4zoobbb9HHia-7BYf9PoGQD-eZQ</recordid><startdate>20120301</startdate><enddate>20120301</enddate><creator>Aaron, Shawn D</creator><creator>Donaldson, Gavin C</creator><creator>Whitmore, George A</creator><creator>Hurst, John R</creator><creator>Ramsay, Tim</creator><creator>Wedzicha, Jadwiga A</creator><general>BMJ Publishing Group Ltd and British Thoracic Society</general><general>BMJ Publishing Group</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20120301</creationdate><title>Time course and pattern of COPD exacerbation onset</title><author>Aaron, Shawn D ; Donaldson, Gavin C ; Whitmore, George A ; Hurst, John R ; Ramsay, Tim ; Wedzicha, Jadwiga A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b558t-cbe6ed64e040d6680a63b8a5a55cc07ae6c48906d03863badb4f97af2a80e4a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Acute Disease</topic><topic>Aged</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>bronchiectasis</topic><topic>Cardiology. Vascular system</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Chronic obstructive pulmonary disease, asthma</topic><topic>COPD epidemiology</topic><topic>COPD exacerbations</topic><topic>COPD mechanisms</topic><topic>COPD pathology</topic><topic>COPD pharmacology</topic><topic>cystic fibrosis</topic><topic>Diaries</topic><topic>diary data</topic><topic>Disease Progression</topic><topic>event history analysis</topic><topic>exacerbation</topic><topic>Female</topic><topic>Forced Expiratory Volume - physiology</topic><topic>Glucocorticoids - therapeutic use</topic><topic>health process</topic><topic>Humans</topic><topic>Infections</topic><topic>logistic regression</topic><topic>lung physiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>medication</topic><topic>Middle Aged</topic><topic>Patients</topic><topic>Pneumology</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Pulmonary Disease, Chronic Obstructive - complications</topic><topic>Pulmonary Disease, Chronic Obstructive - drug therapy</topic><topic>Pulmonary Disease, Chronic Obstructive - physiopathology</topic><topic>Respiration Disorders - etiology</topic><topic>Respiration Disorders - physiopathology</topic><topic>Respiratory Tract Infections - complications</topic><topic>Respiratory Tract Infections - drug therapy</topic><topic>Risk Factors</topic><topic>score function</topic><topic>symptoms</topic><topic>Time Factors</topic><topic>Viral infections</topic><topic>Vital Capacity - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aaron, Shawn D</creatorcontrib><creatorcontrib>Donaldson, Gavin C</creatorcontrib><creatorcontrib>Whitmore, George A</creatorcontrib><creatorcontrib>Hurst, John R</creatorcontrib><creatorcontrib>Ramsay, Tim</creatorcontrib><creatorcontrib>Wedzicha, Jadwiga A</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Thorax</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aaron, Shawn D</au><au>Donaldson, Gavin C</au><au>Whitmore, George A</au><au>Hurst, John R</au><au>Ramsay, Tim</au><au>Wedzicha, Jadwiga A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Time course and pattern of COPD exacerbation onset</atitle><jtitle>Thorax</jtitle><addtitle>Thorax</addtitle><date>2012-03-01</date><risdate>2012</risdate><volume>67</volume><issue>3</issue><spage>238</spage><epage>243</epage><pages>238-243</pages><issn>0040-6376</issn><eissn>1468-3296</eissn><coden>THORA7</coden><abstract>BackgroundThe natural history and time course of the onset of exacerbation events of chronic obstructive pulmonary disease (COPD) is incompletely understood.MethodsA prospective cohort of 212 patients with COPD was monitored using daily symptom diaries for a median of 2.8 years to characterise the time course of COPD exacerbation onset. Decision rules based on weighted self-reported symptoms were used to define opening and closing of exacerbation events. Event time intervals were analysed and logistic regression was used to determine the effects of patient covariates on exacerbation events.ResultsPatients recorded 4439 episodes of worsening respiratory symptoms from baseline; 2444 (55%) events resolved spontaneously and 1995 (45%) resulted in a COPD exacerbation. In 1115 of the 1995 COPD exacerbations (56%) the onset was sudden and the exacerbation threshold was crossed on the same day symptoms began. In contrast, 44% of exacerbations were characterised by gradual onset of symptoms (median duration from symptom onset to exacerbation 4 days). Patients who experienced sudden onset exacerbations had greater mean daily symptom scores (7.86 vs 6.55 points, p&lt;0.001), greater peak symptom scores (10.7 vs 10.2 points, p=0.003), earlier peak symptoms (4.5 vs 8.0 days, p&lt;0.001) and shorter median recovery times back to baseline health status (11 vs 13 days, p&lt;0.001). Multivariable analysis showed that gradual onset exacerbations were statistically associated with a longer duration of exacerbation recovery (OR 1.28, 95% CI 1.06 to 1.54, p=0.010).ConclusionsCOPD exacerbations exhibit two distinct patterns—sudden and gradual onset. Sudden onset exacerbations are associated with increased respiratory symptoms but shorter exacerbation recovery times.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Thoracic Society</pub><pmid>22008189</pmid><doi>10.1136/thoraxjnl-2011-200768</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0040-6376
ispartof Thorax, 2012-03, Vol.67 (3), p.238-243
issn 0040-6376
1468-3296
language eng
recordid cdi_proquest_miscellaneous_922501692
source MEDLINE; BMJ Journals - NESLi2; Alma/SFX Local Collection
subjects Acute Disease
Aged
Anti-Bacterial Agents - therapeutic use
Biological and medical sciences
bronchiectasis
Cardiology. Vascular system
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease, asthma
COPD epidemiology
COPD exacerbations
COPD mechanisms
COPD pathology
COPD pharmacology
cystic fibrosis
Diaries
diary data
Disease Progression
event history analysis
exacerbation
Female
Forced Expiratory Volume - physiology
Glucocorticoids - therapeutic use
health process
Humans
Infections
logistic regression
lung physiology
Male
Medical sciences
medication
Middle Aged
Patients
Pneumology
Prognosis
Prospective Studies
Pulmonary Disease, Chronic Obstructive - complications
Pulmonary Disease, Chronic Obstructive - drug therapy
Pulmonary Disease, Chronic Obstructive - physiopathology
Respiration Disorders - etiology
Respiration Disorders - physiopathology
Respiratory Tract Infections - complications
Respiratory Tract Infections - drug therapy
Risk Factors
score function
symptoms
Time Factors
Viral infections
Vital Capacity - physiology
title Time course and pattern of COPD exacerbation onset
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T17%3A02%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Time%20course%20and%20pattern%20of%20COPD%20exacerbation%20onset&rft.jtitle=Thorax&rft.au=Aaron,%20Shawn%20D&rft.date=2012-03-01&rft.volume=67&rft.issue=3&rft.spage=238&rft.epage=243&rft.pages=238-243&rft.issn=0040-6376&rft.eissn=1468-3296&rft.coden=THORA7&rft_id=info:doi/10.1136/thoraxjnl-2011-200768&rft_dat=%3Cproquest_cross%3E4027103741%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1781812790&rft_id=info:pmid/22008189&rfr_iscdi=true